Evolus is facing off against a much larger drugmaker in Allergan with its launch for new wrinkle-fighter Jeuveau, and now the company's marketing strategy is turning heads. This month, the one-drug company invited medical aesthetics experts to Cancun, Mexico, for a meeting in support of its rollout, spawning a series of favorable social media posts that looked like something out of a Fyre Festival documentary—and critics are calling its ethics into question.
On Wednesday, Evolus said it made its first Jeuveau shipment to about 3,000 practices around the U.S.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.